Wanbury gets nod to settle debt by selling few brands

03 Jun 2019

Wanbury has received approval for debt settlement and fund raising plan by sale of few brands. The Board of Directors of the Company at its meeting held on June 01, 2019 has approved the same.

Wanbury is the fastest growing pharma company and has a strong presence in the domestic branded formulations.

Related Wanbury Ltd. Links:

Wanbury Share Price

95.10 0.10 (0.11%) Apr 23, 18:03
1 Year Price Chart
Company Name CMP
Sun Pharma Inds. 637.65
Dr. Reddys Lab 5066.70
Lupin 1079.00
Piramal Enterprises 1647.40
Cadila Healthcare 571.20
View more..
Sensex vs Wanbury
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323